Table 3:

Hospital Outcomes in OHTx/LVAD Cohorts

	Procedure	Pre		Post		P-Value
OHTx Cohort (2116)		N (1400)	(%)	N (716)	(%)
	Any MCS	221	15.8	304	42.5	<0.001
	ECMO	6	0.4	64	8.9	<0.001
	IABP	190	13.6	244	34.1	<0.001
	Impella	43	3.1	53	7.4	<0.001
	VAD	26	1.9	15	2.1	0.83
	In-Hospital Mortality	76	5.4	40	5.6	0.96
		Mean	St Dev	Mean	St Dev
	LOS	37.9	38.3	40.8	35.0	<0.001
LVAD Cohort (2893)		N (2021)	(%)	N (872)	(%)
	Any MCS	596	29.5	320	36.7	0.00
	ECMO	6	0.3	71	8.1	<0.001
	IABP	464	23.0	211	24.2	0.50
	Impella	174	8.6	111	12.7	0.00
	In-Hospital Mortality	209	10.3	87	10.0	0.82
		Mean	St Dev	Mean	St Dev
	LOS	37.5	28.5	35.5	24.1	0.44
OHTx/LVAD Cohort (5009)		N (3421)	(%)	N (1588)	(%)
	Any MCS	817	23.9	624	39.3	<0.001
	ECMO	12	0.4	135	8.5	<0.001
	IABP	654	19.1	455	28.7	<0.001
	Impella	217	6.3	164	10.3	<0.001
	LVAD	2021	59.1	872	54.9	0.01
	OHTx	1400	40.9	716	45.1	0.01
	In-Hospital Mortality	285	8.3	127	8.0	0.73
		Mean	St Dev	Mean	St Dev
	LOS (days)	37.7	32.8	37.9	29.6	0.01